Methods for Detection of Circulating Tumour Cells and Their Clinical Value in Cancer Patients
Overview
Authors
Affiliations
Currently available analytical methods enable identification, detection and characterization of circulating tumour cells in the peripheral blood and disseminated tumour cells in the bone marrow of breast cancer patients. About 0.01 % of the circulating tumour cells observed in the blood are able to form metastases. Therefore, they could be used for estimation of the risk for metastatic relapse, as a diagnostic tool for patient stratification, early determination of the therapy failure, or potential risk of resistance to the given therapeutic intervention. New therapeutic molecular targets could be identified for management of cancer patients using circulating tumour cell detection. The following review summarizes introduced methods of circulating tumour cell detection and their possible application in clinics.
Islam K, Paul R, Wang S, Zhao Y, Adhikary P, Li Q Microsyst Nanoeng. 2025; 11(1):43.
PMID: 40050640 PMC: 11885814. DOI: 10.1038/s41378-025-00874-x.
Islam K, Paul R, Wang S, Zhao Y, Adhikary P, Li Q ArXiv. 2023; .
PMID: 37744465 PMC: 10516114.
Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer.
Dhaka S, Tripathi R, Chandra Doval D, Mehta A, Maheshwari U, Koyyala V South Asian J Cancer. 2023; 12(1):62-67.
PMID: 36851934 PMC: 9966169. DOI: 10.1055/s-0042-1753477.
Gonell F, Botas A, Brites C, Amoros P, Carlos L, Julian-Lopez B Nanoscale Adv. 2022; 1(7):2537-2545.
PMID: 36132713 PMC: 9418934. DOI: 10.1039/c8na00412a.
Label-free detection of rare circulating tumor cells by image analysis and machine learning.
Wang S, Zhou Y, Qin X, Nair S, Huang X, Liu Y Sci Rep. 2020; 10(1):12226.
PMID: 32699281 PMC: 7376046. DOI: 10.1038/s41598-020-69056-1.